These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 21111984

  • 1. Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy.
    Moreno V, Hernández-Romero D, Vilchez JA, García-Honrubia A, Cambronero F, Casas T, González J, Martínez P, Climent V, de la Morena G, Valdés M, Marín F.
    J Card Fail; 2010 Dec; 16(12):950-6. PubMed ID: 21111984
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy.
    Cambronero F, Vilchez JA, García-Honrubia A, Ruiz-Espejo F, Moreno V, Hernández-Romero D, Bonacasa B, González-Conejero R, de la Morena G, Martínez P, Climent V, Valdés M, Marín F.
    Thromb Res; 2010 Jul; 126(1):e46-50. PubMed ID: 20156645
    [Abstract] [Full Text] [Related]

  • 3. Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy.
    Montoro-García S, Hernández-Romero D, Jover E, García-Honrubia A, Vilchez JA, Casas T, Martínez P, Climent V, Caballero L, Valdés M, Marín F.
    Eur J Intern Med; 2012 Mar; 23(2):169-74. PubMed ID: 22284249
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V, Marín F, Gimeno JR, Ruiz-Espejo F, González J, Feliu E, García-Honrubia A, Saura D, de la Morena G, Valdés M, Vicente V.
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [Abstract] [Full Text] [Related]

  • 5. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M.
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Jenab Y, Pourjafari M, Darabi F, Boroumand MA, Zoroufian A, Jalali A.
    J Cardiol; 2014 Feb; 63(2):140-4. PubMed ID: 24011925
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Kawasaki T, Sakai C, Harimoto K, Yamano M, Miki S, Kamitani T.
    Am J Cardiol; 2013 Sep 15; 112(6):867-72. PubMed ID: 23746480
    [Abstract] [Full Text] [Related]

  • 8. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ.
    Circ Heart Fail; 2010 Jan 15; 3(1):51-8. PubMed ID: 19850699
    [Abstract] [Full Text] [Related]

  • 9. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec 15; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 10. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T, Kitaoka H, Yamanaka S, Hirota T, Baba Y, Hayashi K, Iiyama T, Kumagai N, Tanioka K, Yamasaki N, Matsumura Y, Furuno T, Sugiura T, Doi YL.
    J Am Coll Cardiol; 2013 Oct 01; 62(14):1252-1259. PubMed ID: 23623916
    [Abstract] [Full Text] [Related]

  • 11. Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy.
    Hasler S, Manka R, Greutmann M, Gämperli O, Schmied C, Tanner FC, Biaggi P, Lüscher TF, Keller DI, Gruner C.
    Swiss Med Wkly; 2016 Oct 01; 146():w14285. PubMed ID: 26999566
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O, Watanabe T, Nitobe J, Harada M, Suzuki S, Koyama Y, Kitahara T, Sasaki T, Kubota I.
    J Card Fail; 2007 Mar 01; 13(2):120-7. PubMed ID: 17395052
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High-sensitivity cardiac troponin T in essential hypertension.
    Sato Y, Yamamoto E, Sawa T, Toda K, Hara T, Iwasaki T, Fujiwara H, Takatsu Y.
    J Cardiol; 2011 Nov 01; 58(3):226-31. PubMed ID: 21885250
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A, Abdel-Aty H, Bohl S, Boyé P, Zagrosek A, Dietz R, Schulz-Menger J.
    J Am Coll Cardiol; 2009 Jan 20; 53(3):284-91. PubMed ID: 19147047
    [Abstract] [Full Text] [Related]

  • 18. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
    Esposito A, De Cobelli F, Perseghin G, Pieroni M, Belloni E, Mellone R, Canu T, Gentinetta F, Scifo P, Chimenti C, Frustaci A, Luzi L, Maseri A, Maschio AD.
    Heart; 2009 Mar 20; 95(3):228-33. PubMed ID: 18708417
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.